Aming Zhang

Aming Zhang currently serves as the Head of Analytical Development and QC at Pyxis Oncology, a role assumed in April 2022. Previously, Zhang held an Associate Director position at GSK from January 2020 to July 2022, leading mass spectrometry teams for biopharma portfolio development and contributing to CMC strategy teams. Prior experience includes serving as a Staff Scientist at Regeneron Pharmaceuticals, where leadership was provided for LC-MS support across various product stages, and as a Principal Scientist at GlaxoSmithKline, overseeing phase III enabling mAb programs. Earlier roles included a postdoctoral fellowship at Amgen focused on LC-MS platform development and a summer internship at Genzyme. Zhang earned a Ph.D. in Chemical Engineering from the University of Virginia and a B.S. in Chemical & Biochemical Engineering from Zhejiang University.